Ngā hua rapu - Fabbrocicni G
- E whakaatu ana i te 1 - 1 hua o te 1
-
1
Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study mā Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M
I whakaputaina 2023Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka